Study to Assess the Clinical Efficacy of the Specialized Enteral Tube Nutrition Composition Nutrison Advanced Cubison as a Part of Complex Pressure Ulcers (PU) Therapy
Prospective Multicenter Randomized Controlled Low-interventional Post-registration Study to Assess the Clinical Efficacy of the Specialized Enteral Tube Nutrition Composition Nutrison Advanced Cubison as a Part of Complex Pressure Ulcers (PU) Therapy Versus Standard Enteral Tube Nutrition Products
1 other identifier
observational
60
1 country
3
Brief Summary
A large number of studies are devoted to studying the effect of patient nutrition on the occurrence and treatment of pressure ulcers. Several studies, including the US National Long-term Treatment of Pressure Ulcers Study, have shown that weight loss and malnutrition were associated with a higher risk of pressure ulcers. One of the successful products specially created for the treatment of pressure ulcers and taking into account the results of research is the high-protein, energy-rich, ready-to-use enteral tube feeding food product Nutrison Advanced Cubison. It is a complete enteral nutritional supplement with an innovative nutrient composition for patients with chronic wounds, including pressure ulcers, or at increased risk of developing them. Taking into account the available data, it seems expedient to continue studying the unique combination of nutrients that make up the study food product Nutrison Advanced Cubison in order to develop the most effective nutritional protocols for patients at risk for the treatment and prevention of pressure ulcers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2021
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedFirst Submitted
Initial submission to the registry
July 12, 2022
CompletedFirst Posted
Study publicly available on registry
July 18, 2022
CompletedJuly 18, 2022
July 1, 2022
6 months
July 12, 2022
July 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Changes in the area of pressure ulcers in both groups during the study
up to 4 weeks
The proportion of patients in both groups with a decrease in the area of the pressure ulcer by 20% or more by the date of completion of observations
up to 4 weeks
Changes in the Pressure Ulcer Scale for Healing values in both groups during the study
Pressure Ulcer Scale for Healing (PUSH) is a common tool to monitor pressure healing over time. The PUSH Tool monitors three parameters: surface area of the wound, wound exudate and type of wound tissue. Minimum value is 0, maximum value is 17. The bigger scale is the worse
up to 4 weeks
Secondary Outcomes (5)
Duration of treatment for pressure ulcers in study patients
up to 4 weeks
Frequency and duration of infectious complications of pressure ulcers in study patients
up to 4 weeks
Concentration of the blood albumin at the beginning and at the end of observations
up to 4 weeks
Concentration of the blood lymphocytes at the beginning and at the end of observations
up to 4 weeks
Concentration of the C-reactive protein at the beginning and at the end of observations
up to 4 weeks
Study Arms (2)
The Study Group
30 adult patients aged 30-75 years to receive a specialized tube feeding product Nutrison Advanced Cubison (20% protein energy 100 kcal, 5.5 g protein, 0.85 g arginine, 38 mg of vitamin C and 2 mg of zinc) in a volume not exceeding 1.5 liters / day and, if necessary, to replenish nutritional needs based on the total daily intake of 30-35 kcal / kg / day and 1.2-1.5 g of protein / kg body weight / day according to the recommendations for nutritional support for patients with pressure ulcers during the entire observation period
The Control Group
30 patients aged 30-75 years to receive a standard (available in the clinic) tube feeding product (energetically similar to the product in group 1) with a standard content of arginine, vitamins and minerals from calculating the total daily intake of 30-35 kcal / kg / day and 1.2-1.5 g protein / kg body weight / day according to the recommendations for nutritional support for patients with pressure ulcers during the entire observation period
Interventions
(20% protein energy 100 kcal, 5.5 g protein, 0.85 g arginine, 38 mg of vitamin C and 2 mg of zinc) in a volume not exceeding 1.5 liters / day and, if necessary, to replenish nutritional needs based on the total daily intake of 30-35 kcal / kg / day and 1.2-1.5 g of protein / kg body weight / day according to the recommendations for nutritional support
Eligibility Criteria
60 patients hospitalized with strokes or traumatic brain injury, who are on tube feeding and with the presence of pressure ulcers of 2-3 stages identified at baseline or during hospital stay
You may qualify if:
- Patients diagnosed with stroke / TBI and who are on tube feeding
- Presence of pressure ulcers of 2-3 stages
- Informed voluntary consent to medical intervention is formalized in accordance with the requirements of the Federal Law of 21.11.2011 N 323-FZ "On the basics of protecting the health of citizens in the Russian Federation."
You may not qualify if:
- Hemodynamically unstable patients
- Severe renal impairment (GFR \<30 ml / min)
- Moderate or severe liver failure (Child-Pugh Class B or C)
- Oncological diseases (lasting more than 5 years)
- Hypersensitivity to any component of the test food mixture
- Uncertainty of the investigator about the willingness or ability of the subject to comply with the protocol requirements
- Any other medical or non-medical reasons that, in the opinion of the physician, may prevent the patient from participating in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Enrollme.ru, LLClead
- Danone Nutriciacollaborator
Study Sites (3)
GAUZ Bryansk city hospital №1
Bryansk, Russia
GBUZ GKB named after VV Vinogradov DZM
Moscow, Russia
Hospital named after V.D. Seredavin
Samara, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mikhail Getman, Dr
Enrollme.ru, LLC
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2022
First Posted
July 18, 2022
Study Start
June 1, 2021
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
July 18, 2022
Record last verified: 2022-07